Tryptamine Therapeutics launches on ASX with innovative psilocin formulation
–News Direct– Tryptamine Therapeutics Inc. (ASX: TYP) CEO Jason Carroll sits down with Jonathan Jackson in the proactive studio to talk about the start of trading on the Australian Securities …
Tryptamine Therapeutics launches on ASX with innovative psilocin formulation Read More